From their Aug 1 LANI Phase 2 topline data announcement:
"The Company plans to provide a detailed update on the full efficacy and safety results of the Phase 2 IGLOO trial, the status of the LANI program and its corporate strategy during its fourth quarter and fiscal year-end earnings call in early September."
Monday is mid-September...promises promises.
- Forums
- ASX - By Stock
- BTA
- Waiting
Waiting
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)